Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Larimar Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 3.91 · gapped below the open, never looked back. High/low 3.91 at 4:00 pm ET, 3.73 at 10:00 am ET.
162 institutional managers report a position in Larimar Therapeutics, Inc. worth $294.6M between them, filed on form 13F for the quarter ending 2026-06-30. 15 of them hold 80% of it, the largest being Deerfield Management Co at 36.86%.
137 more managers in the register
15 managers hold 80% of the $294.6M institutional base. The other 147 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
LRMR (Larimar Therapeutics, Inc.) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
via Deerfield Management Co · 36.86% of LRMR, 22.32% of NUVL
via Deerfield Management Co, Marshall Wace LLP · 36.86% of LRMR, 13.83% of ADAG
via Deerfield Management Co, RTW Investments, LLC, Marshall Wace LLP +3 more · 36.86% of LRMR, 6.24% of SVRA
via Blue Owl Capital Holdings LP, RTW Investments, LLC, Alyeska Investment Group, L.P. +1 more · 9.49% of LRMR, 8.99% of AKTS
via Blue Owl Capital Holdings LP, RTW Investments, LLC · 9.49% of LRMR, 14.72% of IMA
via Blue Owl Capital Holdings LP, Qube Research & Technologies Ltd · 9.49% of LRMR, 20.81% of FLD
Managers holding a meaningful stake in LRMR also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.